ALEXANDRIA, Va., June 18 -- United States Patent no. 12,324,805, issued on June 10, was assigned to LDN Pharma Ltd. (London).
"Cancer treatment" was invented by Wai Liu (London).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention is based on the finding that the inhibition of the proliferation of cancer cells by cannabinoids is brought about more effectively by combined treatment with low dose naltrexone (LDN) or 6-Beta-naltrexone (6BN), a metabolite of naltrexone. There is provided a pharmaceutical composition comprising naltrexone or a metabolite thereof or an analogue thereof, for use in the treatment of cancer within a subject, wherein a therapeutically effective amount of the naltrexone ...